The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications?

被引：2
|
作者：
Leko, Andras H. [1 ,2 ,3 ]
Ray, Lara A. [4 ,5 ]
Leggio, Lorenzo [1 ,2 ,6 ,7 ,8 ]
机构：
[1] NIDA, Clin Psychoneuroendocrinol & Neuropsychopharmacol, Translat Addict Med Branch, Intramural Res Program,NIH, Bethesda, MD 20892 USA
[2] NIAAA, Div Intramural Clin & Biol Res, NIH, Bethesda, MD 20892 USA
[3] NIH, Ctr Compuls Behav, Intramural Res Program, Bethesda, MD USA
[4] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA
[5] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA
[6] Brown Univ, Ctr Alcohol & Addict Studies, Dept Behav & Social Sci, Providence, RI USA
[7] Johns Hopkins Univ, Sch Med, Dept Med, Div Addict Med, Baltimore, MD USA
[8] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC USA
来源：
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 47卷 / 05期
关键词：
RECEPTOR; NEUROINFLAMMATION; EXPRESSION; DRINKING;
D O I：
10.1111/acer.15049
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：843 / 847
页数：5
相关论文
共 50 条
  • [41] Patient perspectives on medications for alcohol use disorder: A systematic scoping review
    Tomlinson, Devin C.
    Florimbio, Autumn Rae
    Lee, Carol A.
    Ilgen, Mark A.
    Lin, Lewei A.
    Coughlin, Lara N.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2025,
  • [42] EFFECTIVENESS AND SAFETY OF MEDICATIONS USED TO TREAT ALCOHOL USE DISORDER IN WOMEN
    Agabio, R.
    Preti, A.
    Gessa, G. L.
    Franconi, F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 138A - 138A
  • [43] A Practice-Quit Model for Screening Medications for Alcohol Use Disorder
    Ray, Lara
    Nieto, Steven
    Grodin, Erica
    Basker-Ville, Wave-Ananda
    Ho, Diana
    Russell, Riley
    Gillis, Artha
    Miotto, Karen
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 416 - 416
  • [44] Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
    Antonelli, Mariangela
    Sestito, Luisa
    Tarli, Claudia
    Addolorato, Giovanni
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 103 : 13 - 22
  • [45] A novel human laboratory model for screening medications for alcohol use disorder
    Diana Ho
    Brandon Towns
    Erica N. Grodin
    Lara A. Ray
    Trials, 21
  • [46] A practice-quit model for screening medications for alcohol use disorder
    Baskerville, W.
    Nieto, S.
    Grodin, E. N.
    Ho, D.
    Russell, R.
    Gillis, A.
    Miotto, K.
    Ray, L. A.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 239 - 239
  • [47] A novel human laboratory model for screening medications for alcohol use disorder
    Ho, Diana
    Towns, Brandon
    Grodin, Erica N.
    Ray, Lara A.
    TRIALS, 2020, 21 (01)
  • [48] Associations Between Inpatient Induction on Medications for Opioid Use Disorder and Postdischarge Medications for Opioid Use Disorder Adherence, Overdose, and Service Use
    Noam, Krista R.
    Schmutte, Timothy J.
    Pirard, Sandrine
    Bourdon, Carol
    Langless, Daniel
    Plant, Robert
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (03) : E199 - E201
  • [49] A New 'Vicious Cycle': Bidirectional Interactions Between Myeloma Cells and Adipocytes
    Campbell, Heather Fairfield
    Farrell, Mariah
    Falank, Carolyne
    Dudakovic, Amel
    Costa, Samantha
    DeMambro, Victoria
    Pettitt, Jessica
    van Wijnen, Andre J.
    McDonald, Michelle
    Reagan, Michaela
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E88 - E89
  • [50] The Importance of Identifying Characteristics Underlying the Vulnerability to Develop Alcohol Use Disorder
    Petrakis, Ismene L.
    AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (11): : 1034 - 1035
12345